Summary
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Singaporean pharmaceuticals market recorded revenues of $7.3 billion in 2024, representing a compound annual growth rate (CAGR) of 4.9% between 2019 and 2024.
- The central nervous system drugs segment accounted for the market's largest proportion in 2024, with total revenues of $1.2 billion, equivalent to 17.0% of the market's overall value.
- Singapore captured a share of 2.0% in the Asia-Pacific pharmaceuticals market in 2024. According to the data from Statistics Singapore, the population in Singapore reached 6.0 million in 2024 from 5.9 million in 2023. The rising population resulted in an
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Singapore pharmaceuticals market by value in 2024?
- What will be the size of the Singapore pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Singapore's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Novartis AG
8.2. Merck & Co Inc
8.3. Pfizer Inc
8.4. Sanofi
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Singapore pharmaceuticals market value: $ million, 2019-24
Table 2: Singapore pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Singapore pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Singapore pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Singapore pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Novartis AG: Key Facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Merck & Co Inc: Key Facts
Table 10: Merck & Co Inc: Annual Financial Ratios
Table 11: Merck & Co Inc: Key Employees
Table 12: Pfizer Inc: Key Facts
Table 13: Pfizer Inc: Annual Financial Ratios
Table 14: Pfizer Inc: Key Employees
Table 15: Pfizer Inc: Key Employees Continued
Table 16: Sanofi: Key Facts
Table 17: Sanofi: Annual Financial Ratios
Table 18: Sanofi: Key Employees
Table 19: Sanofi: Key Employees Continued
Table 20: Singapore Size of Population (Million), 2020-24
Table 21: Singapore Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Singapore GDP (Current Prices, $ Billion), 2020-24
Table 23: Singapore Inflation, 2020-24
Table 24: Singapore Consumer Price Index (Absolute), 2020-24
Table 25: Singapore Exchange Rate, 2019-24
List of Figures
Figure 1: Singapore pharmaceuticals market value: $ million, 2019-24
Figure 2: Singapore pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Singapore pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Singapore pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2024
